Matches in SemOpenAlex for { <https://semopenalex.org/work/W4248723218> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4248723218 endingPage "591" @default.
- W4248723218 startingPage "590" @default.
- W4248723218 abstract "Autoimmune thyroid diseases are reported in no treated hepatitis C virus (HCV) infection. The standard interferon alpha (IFNα) treatment is associated with an increase of thyroid damage and dysfunction. The present cohort prospective study compared thyroid function and autoimmunity in HCV patients’ monoinfected and coinfected HCV–HIV at baseline, during and after IFNα therapy.We studied 790 HCV infected patients: G1 (monoinfected HCV: N = 580) and G2 (HCV–HIV coinfected: N = 210). They were evaluated for thyroid function and thyroid tiroperoxidase antibodies (TPOAb) at baseline and 235 patients (G1: 183; G2: 52) post IFNα therapy.If thyroid dysfunction (TD) was diagnosed, they were reevaluated at 12 month after discontinuation to determine whether the TD was transitory or definitive.No difference was found in the prevalence of TD at baseline in G1 (7.6%) and G2 (9%). However, monoinfected patients showed a higher prevalence of TPOAb positivity with a women preponderance in this group. There was no difference in TD between both groups during IFNα therapy (G1 23.5% vs G2 19.2%). In G1 the autoimmune TD was higher than in G2 (67.4% vs 30%, p = 0.02). Autoimmune TD during IFNα tended to evolve to definitive hypothyroidism and non-autoimmune TD recovered euthyroidism after IFNα discontinuation. The presence of positive TPOAb (RR 3.55) and female gender (RR 2.4) were associated with the development of TD with IFNα therapy.Our hypothesis is the importance of HCV in G1 and G2, combined with IFNα in triggering TD and TPOAb positivity, not described in other diseases’ applications.El presente estudio prospectivo de cohorte evaluó y comparó la función y la autoinmunidad tiroidea en pacientes con virus de la hepatitis C (VHC) monoinfectados y coinfectados con VHC-virus de la inmunodeficiencia humana (VIH) al inicio, durante y después de la terapia estándar con interferón alfa (IFNα).Se estudiaron 790 pacientes infectados por VHC: G1 (VHC monoinfectados: N = 580) y G2 (coinfección por VHC-VIH: N = 210). Se evaluó la función tiroidea y los anticuerpos anti-tiroperoxidasa (ATPO) al inicio del estudio, y a 235 pacientes tratados con IFNα (G1: 183; G2: 52). Si se diagnosticó disfunción tiroidea (DT), estos fueron reevaluados 12 meses posteriores al tratamiento para determinar si esta era transitoria o definitiva.No se encontraron diferencias en la prevalencia de DT en forma basal G1 (7,6%) vs. G2 (9%). Los pacientes monoinfectados mostraron una mayor prevalencia de positividad de ATPO, siendo preponderante el sexo femenino en el G1. No hubo diferencias en la DT entre ambos grupos con IFNα (G1 23,5 vs. G2 19,2%). En G1, la DT autoinmune fue mayor que en G2 (67,4 vs. 30%; p = 0,02). La DT autoinmune con IFNα tendió a evolucionar hacia un hipotiroidismo definitivo, mientras que la DT no autoinmune fue transitoria. Tuvieron mayor riesgo de DT durante el tratamiento los pacientes que presentaban ATPO positivos previos (RR: 3,55) y el sexo femenino (RR: 2,4).Planteamos como hipótesis la importancia del VHC en G1 y G2, combinado con IFNα en el desarrollo de la DT y positividad de los ATPO, no descripta en su uso en otras enfermedades." @default.
- W4248723218 created "2022-05-12" @default.
- W4248723218 creator A5012553683 @default.
- W4248723218 creator A5021852885 @default.
- W4248723218 creator A5023488259 @default.
- W4248723218 creator A5046837653 @default.
- W4248723218 creator A5067243341 @default.
- W4248723218 date "2019-11-01" @default.
- W4248723218 modified "2023-09-25" @default.
- W4248723218 title "Transient osteoporosis of the hip during pregnancy" @default.
- W4248723218 doi "https://doi.org/10.1016/j.endien.2019.03.014" @default.
- W4248723218 hasPublicationYear "2019" @default.
- W4248723218 type Work @default.
- W4248723218 citedByCount "0" @default.
- W4248723218 crossrefType "journal-article" @default.
- W4248723218 hasAuthorship W4248723218A5012553683 @default.
- W4248723218 hasAuthorship W4248723218A5021852885 @default.
- W4248723218 hasAuthorship W4248723218A5023488259 @default.
- W4248723218 hasAuthorship W4248723218A5046837653 @default.
- W4248723218 hasAuthorship W4248723218A5067243341 @default.
- W4248723218 hasConcept C126322002 @default.
- W4248723218 hasConcept C159654299 @default.
- W4248723218 hasConcept C163764329 @default.
- W4248723218 hasConcept C203014093 @default.
- W4248723218 hasConcept C2522874641 @default.
- W4248723218 hasConcept C2776408679 @default.
- W4248723218 hasConcept C2776455275 @default.
- W4248723218 hasConcept C2778715236 @default.
- W4248723218 hasConcept C2993291352 @default.
- W4248723218 hasConcept C50181227 @default.
- W4248723218 hasConcept C526584372 @default.
- W4248723218 hasConcept C71924100 @default.
- W4248723218 hasConcept C72563966 @default.
- W4248723218 hasConcept C90924648 @default.
- W4248723218 hasConceptScore W4248723218C126322002 @default.
- W4248723218 hasConceptScore W4248723218C159654299 @default.
- W4248723218 hasConceptScore W4248723218C163764329 @default.
- W4248723218 hasConceptScore W4248723218C203014093 @default.
- W4248723218 hasConceptScore W4248723218C2522874641 @default.
- W4248723218 hasConceptScore W4248723218C2776408679 @default.
- W4248723218 hasConceptScore W4248723218C2776455275 @default.
- W4248723218 hasConceptScore W4248723218C2778715236 @default.
- W4248723218 hasConceptScore W4248723218C2993291352 @default.
- W4248723218 hasConceptScore W4248723218C50181227 @default.
- W4248723218 hasConceptScore W4248723218C526584372 @default.
- W4248723218 hasConceptScore W4248723218C71924100 @default.
- W4248723218 hasConceptScore W4248723218C72563966 @default.
- W4248723218 hasConceptScore W4248723218C90924648 @default.
- W4248723218 hasIssue "9" @default.
- W4248723218 hasLocation W42487232181 @default.
- W4248723218 hasOpenAccess W4248723218 @default.
- W4248723218 hasPrimaryLocation W42487232181 @default.
- W4248723218 hasRelatedWork W1684746149 @default.
- W4248723218 hasRelatedWork W2021487735 @default.
- W4248723218 hasRelatedWork W2024800898 @default.
- W4248723218 hasRelatedWork W2056082154 @default.
- W4248723218 hasRelatedWork W2091818847 @default.
- W4248723218 hasRelatedWork W2143681435 @default.
- W4248723218 hasRelatedWork W2312212505 @default.
- W4248723218 hasRelatedWork W2359029718 @default.
- W4248723218 hasRelatedWork W2432821796 @default.
- W4248723218 hasRelatedWork W504429 @default.
- W4248723218 hasVolume "66" @default.
- W4248723218 isParatext "false" @default.
- W4248723218 isRetracted "false" @default.
- W4248723218 workType "article" @default.